Literature DB >> 3100338

Pathways to chronic inflammation in rheumatoid synovitis.

D Cavender, D Haskard, C L Yu, T Iguchi, P Miossec, N Oppenheimer-Marks, M Ziff.   

Abstract

Postcapillary venules resembling the high endothelial venules (HEVs) of lymphoid tissues have often been observed at sites of chronic inflammation. We have therefore postulated that such venules may be an important site of lymphocyte migration into rheumatoid synovial membrane and that inflammatory cell products may act on endothelial cells (ECs) to increase lymphocyte emigration. Electron microscopic examination of rheumatoid synovial membranes showed that a strong correlation existed between the proportion of lymphocytes in perivascular tissue and the height/base ratio of the ECs in those areas. In addition, binding experiments showed that peripheral blood mononuclear cells preferentially bound to ECs in sections of rheumatoid synovial membrane that had the morphological appearance of HEVs. In vitro binding experiments, in which lymphocyte adhesion to human umbilical vein EC monolayers was measured, showed that adhesion was enhanced by preincubation of the ECs with interferon-gamma or interleukin 1 (IL 1). The central role of IL 1 in increasing lymphocyte migration into the rheumatoid synovial membrane was also supported by the findings that IL 1 is chemotactic for lymphocytes, ECs can secrete IL 1, and IL 1 activity is readily detectable in synovial fluids of rheumatoid arthritis patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3100338

Source DB:  PubMed          Journal:  Fed Proc        ISSN: 0014-9446


  18 in total

Review 1.  Combination chemotherapy in rheumatoid arthritis.

Authors:  P M Brooks; A C Schwarzer
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

Review 2.  The role of leukocyte adhesion molecules in cellular interactions: implications for the pathogenesis of inflammatory synovitis.

Authors:  B F Haynes; L P Hale; S M Denning; P T Le; K H Singer
Journal:  Springer Semin Immunopathol       Date:  1989

Review 3.  Lymphocyte traffic, endothelium, and rheumatoid arthritis.

Authors:  D Haskard
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

4.  Cultured human endothelial cells stimulated with cytokines or endotoxin produce an inhibitor of leukocyte adhesion.

Authors:  M E Wheeler; F W Luscinskas; M P Bevilacqua; M A Gimbrone
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

5.  Mechanisms of lymphocyte adhesion to endothelial cells: studies using a LFA-1-deficient cell line.

Authors:  D O Haskard; S Strobel; M Thornhill; C Pitzalis; R J Levinsky
Journal:  Immunology       Date:  1989-01       Impact factor: 7.397

6.  Systemic lupus erythematosus with necrotizing vasculitis and upregulated expression of VLA-4 antigen.

Authors:  T Takeuchi; K Aoki; J Koide; H Sekine; T Abe
Journal:  Clin Rheumatol       Date:  1995-05       Impact factor: 2.980

Review 7.  Defining a role for fibroblasts in the persistence of chronic inflammatory joint disease.

Authors:  C D Buckley; A Filer; O Haworth; G Parsonage; M Salmon
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

8.  Increased binding of synovial T lymphocytes from rheumatoid arthritis to endothelial-leukocyte adhesion molecule-1 (ELAM-1) and vascular cell adhesion molecule-1 (VCAM-1).

Authors:  A A Postigo; R Garcia-Vicuña; F Diaz-Gonzalez; A G Arroyo; M O De Landázuri; G Chi-Rosso; R R Lobb; A Laffon; F Sánchez-Madrid
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

9.  Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts.

Authors:  M Kaneko; H Inoue; R Nakazawa; N Azuma; M Suzuki; S Yamauchi; S B Margolin; K Tsubota; I Saito
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

10.  Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration.

Authors:  G Yanni; A Whelan; C Feighery; W Quinlan; J Symons; G Duff; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.